A Class II FDA recall over an undeclared fish-derived collagen source sits alongside a finalized FTC advertising order and a dozen contemporaneous supplement recalls. This brief separates labeling defects from contamination findings, distinguishes agency orders from allegations, and cautions against treating any single enforcement record as evidence of a sector-wide trend.
Connected intelligence
Explore the ingredient records and WQ formulas directly connected to this editorial review.
Continue the research
Latest from this journal.
Recent publications on kava, olive leaf, lavender, and turmeric reveal a shared research focus: verifying what botanical extracts actually contain through rigorous...
Read article →
A structured comparison of Andrographis paniculata research — separating in vitro, animal, and human clinical findings on immune and digestive-related outcomes —...
Read article →
A review of human, animal, and laboratory studies on Amla (Emblica officinalis), examining lipid, glucose, and antioxidant research while distinguishing preparation types,...
Read article →
